PE20060491A1 - Dispositivo transdermico de transmision de farmaco que incluye un refuerzo oclusivo - Google Patents

Dispositivo transdermico de transmision de farmaco que incluye un refuerzo oclusivo

Info

Publication number
PE20060491A1
PE20060491A1 PE2005001195A PE2005001195A PE20060491A1 PE 20060491 A1 PE20060491 A1 PE 20060491A1 PE 2005001195 A PE2005001195 A PE 2005001195A PE 2005001195 A PE2005001195 A PE 2005001195A PE 20060491 A1 PE20060491 A1 PE 20060491A1
Authority
PE
Peru
Prior art keywords
reinforcement
layer
transmission device
device including
transdermal drug
Prior art date
Application number
PE2005001195A
Other languages
English (en)
Inventor
David Kanios
Juan A Mantelle
Viet Nguyen
Original Assignee
Noven Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noven Pharma filed Critical Noven Pharma
Publication of PE20060491A1 publication Critical patent/PE20060491A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

SE REFIERE A UN SISTEMA TRANSDERMICO QUE COMPRENDE: A) UN ADHESIVO SENSIBLE A LA PRESION QUE COMPRENDE POLIMEROS SELECCIONADOS ENTRE POLIBUTILENO, POLISOPRENO, POLISOBUTILENO, ENTRE OTROS; QUE COMPRENDE ENTRE 5 A 97% (P/P); B) FARMACOS TALES COMO AGONISTAS ß-ADRENERGICO, INHIBIDORES ALDOSA REDUCTASA, ANESTESICOS ENTRE OTROS; SELECCIONADOS ENTRE CLONIDINA, LORATADINA, HALOPERIDOL, ENTRE OTROS; QUE COMPRENDE ENTRE 0,1 A 50% (P/P); Y C) UNA CAPA DE REFUERZO OCLUSIVO, FORMADO POR UNA PLURALIDAD DE CAPAS DONDE LA PRIMERA CAPA ESTA FORMADA DE UN MATERIAL SELECCIONADO ENTRE ACRILONITRILO, POLICARBONATO, POLIESTER, ENTRE OTROS; Y UNA SEGUNDA CAPA FORMADA POR POLIURETANO, NYLON, POLIESTIRENO, ENTRE OTROS; TIENE UN ESPESOR ENTRE 0,2 A 3 MM Y PRESENTA UNA VELOCIDAD DE TRANSMISION DE VAPOR DE HUMEDAD ENTRE 0.5 A 1500 G/M2/24HRS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO DE PREPARACION. ESTE SISTEMA TRANSDERMICO PROPORCIONA PERFILES ACEPTABLES DE LIBERACION DE FARMACO POR UN PERIODO DE TIEMPO DE HASTA SIETE DIAS O MAS
PE2005001195A 2004-10-08 2005-10-10 Dispositivo transdermico de transmision de farmaco que incluye un refuerzo oclusivo PE20060491A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61686104P 2004-10-08 2004-10-08

Publications (1)

Publication Number Publication Date
PE20060491A1 true PE20060491A1 (es) 2006-07-19

Family

ID=36203400

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005001195A PE20060491A1 (es) 2004-10-08 2005-10-10 Dispositivo transdermico de transmision de farmaco que incluye un refuerzo oclusivo

Country Status (9)

Country Link
US (5) US20060078604A1 (es)
EP (1) EP1807033B1 (es)
AR (1) AR053309A1 (es)
CA (1) CA2583340C (es)
ES (1) ES2596809T3 (es)
MX (1) MX2007004315A (es)
PE (1) PE20060491A1 (es)
TW (1) TW200628175A (es)
WO (1) WO2006044206A2 (es)

Families Citing this family (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030170195A1 (en) * 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
ATE288256T1 (de) * 1999-01-14 2005-02-15 Noven Pharma Dermale zusammensetzungen
PE20050496A1 (es) * 2003-07-24 2005-06-12 Smithkline Beecham Corp Peliculas que se disuelven por via oral
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
US20060078602A1 (en) 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Device for transdermal administration of drugs including acrylic polymers
CA2583340C (en) * 2004-10-08 2015-09-08 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
US8372040B2 (en) 2005-05-24 2013-02-12 Chrono Therapeutics, Inc. Portable drug delivery device including a detachable and replaceable administration or dosing element
KR100764679B1 (ko) * 2005-07-22 2007-10-09 익수제약 주식회사 파록세틴을 함유하는 경피투여용 패취제
WO2007014241A1 (en) 2005-07-25 2007-02-01 Boston Scientific Scimed, Inc. Pelvic floor repair system
JP5058531B2 (ja) 2005-09-09 2012-10-24 日東電工株式会社 ビソプロロール含有貼付製剤
JP4945228B2 (ja) * 2005-12-13 2012-06-06 日東電工株式会社 ビソプロロール含有貼付製剤
JP5015562B2 (ja) * 2005-12-13 2012-08-29 日東電工株式会社 貼付製剤
WO2007117581A2 (en) * 2006-04-06 2007-10-18 Collegium Pharmaceutical, Inc. Stabilized transdermal bupropion preparations
WO2008001204A2 (en) * 2006-06-29 2008-01-03 Antares Pharma Ipl Ag Transdermal compositions of pramipexole having enhanced permeation properties
EP2037999B1 (en) 2006-07-07 2016-12-28 Proteus Digital Health, Inc. Smart parenteral administration system
EP2041214A4 (en) 2006-07-10 2009-07-08 Medipacs Inc SUPERELASTIC EPOXY HYDROGEL
ES2657887T3 (es) * 2006-07-14 2018-03-07 Hisamitsu Pharmaceutical Co., Inc. Preparación adhesiva
WO2008056139A2 (en) * 2006-11-08 2008-05-15 Regen Therapeutics Plc Transdermal therapy
US20080107719A1 (en) * 2006-11-08 2008-05-08 Sukhon Likitlersuang Transdermal drug delivery system
DE102006054733A1 (de) * 2006-11-21 2008-05-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit
RU2440811C2 (ru) * 2007-03-08 2012-01-27 Нитто Денко Корпорейшн Устройство для трансдермального введения бисопролола
WO2009026133A2 (en) * 2007-08-17 2009-02-26 Alza Corporation Transdermal bisoprolol delivery system
WO2009026135A2 (en) * 2007-08-17 2009-02-26 Alza Corporation Controlled transdermal bisoprolol delivery system
US9125979B2 (en) 2007-10-25 2015-09-08 Proteus Digital Health, Inc. Fluid transfer port information system
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
US9995295B2 (en) 2007-12-03 2018-06-12 Medipacs, Inc. Fluid metering device
KR100929560B1 (ko) * 2008-01-09 2009-12-03 에코 퍼시픽 엘티디 그라니세트론을 함유한 매트릭스 형태의 경피 흡수제
US20110104247A1 (en) * 2008-03-25 2011-05-05 Takeshi Ito Composition for stabilizing beta-blocker and transdermally absorbable preparation comprising the same
US9449150B2 (en) 2008-04-24 2016-09-20 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US9282927B2 (en) 2008-04-24 2016-03-15 Invention Science Fund I, Llc Methods and systems for modifying bioactive agent use
US20100029909A1 (en) * 2008-05-23 2010-02-04 Northwestern University Compositions and methods comprising magnetic resonance contrast agents
US20090317451A1 (en) * 2008-08-26 2009-12-24 Hauser Ray L Pressure-sensitive adhesive for skin surface and/or transdermal substance delivery
NZ591834A (en) 2008-10-02 2011-12-22 Mylan Inc Method of making a multilayer adhesive laminate
WO2010065489A1 (en) * 2008-12-02 2010-06-10 Sciele Pharma, Inc. Alpha2-adrenergic agonist and angiotensin ii receptor antagonist composition
DE102009008256A1 (de) * 2009-02-10 2010-08-12 Lts Lohmann Therapie-Systeme Ag Prodrugs vom Typ N-hydroxylierter Amidine, Guanidine und/oder Aminohydrazone zur Applikation über die Haut
NZ596881A (en) * 2009-06-12 2013-06-28 Pharmacorp Cc Phentermine liquid dosage form
US20090318568A1 (en) * 2009-08-26 2009-12-24 Hauser Ray L Adherent coating for tissue surface and/or trans-tissue surface substance delivery
WO2011032011A1 (en) 2009-09-10 2011-03-17 Medipacs, Inc. Low profile actuator and improved method of caregiver controlled administration of therapeutics
DE102009056746A1 (de) * 2009-12-04 2011-06-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung von Peptiden
US20110172637A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Drug delivery device including tissue support structure
US20110172645A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Wearable drug delivery device including integrated pumping and activation elements
US20110172609A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Microneedle component assembly for drug delivery device
SG182824A1 (en) 2010-02-01 2012-09-27 Proteus Biomedical Inc Two-wrist data gathering system
RU2587795C2 (ru) 2010-02-01 2016-06-20 Проутьюс Диджитал Хэлс, Инк. Система сбора данных
US9500186B2 (en) 2010-02-01 2016-11-22 Medipacs, Inc. High surface area polymer actuator with gas mitigating components
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
BR112012024356A2 (pt) 2010-03-26 2016-05-24 Philip Morris Products Sa inibição de irritação sensorial durante o consumo de tabaco não fumável
KR101292768B1 (ko) * 2010-04-23 2013-08-05 아이큐어 주식회사 경피 흡수 제제
JP5820469B2 (ja) 2010-04-30 2015-11-24 テイコク ファーマ ユーエスエー インコーポレーテッド プロピニルアミノインダンの経皮組成物
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
DE102010040299A1 (de) * 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
WO2012061556A1 (en) 2010-11-03 2012-05-10 Flugen, Inc. Wearable drug delivery device having spring drive and sliding actuation mechanism
CN103476404B (zh) 2011-03-24 2017-09-29 帝国制药美国公司 包含活性剂层和活性剂转化层的透皮组合物
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
US9925264B2 (en) 2011-05-10 2018-03-27 Itochu Chemical Frontier Corporation Non-aqueous patch
MX349572B (es) 2011-05-10 2017-08-03 Itochu Chemical Frontier Corp Parche no acuoso.
EP2729148A4 (en) 2011-07-06 2015-04-22 Parkinson S Inst COMPOSITIONS AND METHODS FOR TREATING SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE
JP5912928B2 (ja) 2011-07-20 2016-04-27 日東電工株式会社 貼付製剤
DK2823815T3 (en) 2011-09-27 2018-08-06 Itochu Chemical Frontier Corp NON-DIFFICULT PLASTER
JP5913614B2 (ja) 2011-11-09 2016-04-27 テイコク ファーマ ユーエスエー インコーポレーテッド 皮膚新生物の処置方法
US9045403B2 (en) 2012-02-29 2015-06-02 Coyote Pharmaceuticals, Inc. Geranyl geranyl acetone (GGA) derivatives and compositions thereof
US20140171516A1 (en) * 2012-02-29 2014-06-19 Coyote Pharmaceuticals, Inc. Geranylgeranylacetone formulations
EP2847249A4 (en) 2012-03-14 2016-12-28 Medipacs Inc SMART POLYMER MATERIALS WITH EXCESSIVE REACTIVE MOLECULES
US9408802B1 (en) * 2012-03-22 2016-08-09 Prosolus, Inc. Seven day drug in adhesive transdermal delivery
DE102012205493A1 (de) * 2012-04-03 2013-10-10 Acino Ag Einen Dopamin-Agonisten enthaltendes transdermales Applikationssystem
US20140045801A1 (en) * 2012-08-09 2014-02-13 Mylan Inc. Pramipexole transdermal delivery for severe headaches
JP5914266B2 (ja) 2012-08-31 2016-05-11 日東電工株式会社 貼付製剤
US9119808B1 (en) 2012-10-08 2015-09-01 Coyote Pharmaceuticals, Inc. Treating neurodegenerative diseases with GGA or a derivative thereof
CA2891467A1 (en) * 2012-10-15 2014-04-24 Noven Pharmaceuticals, Inc. Compositions and methods for the transdermal delivery of methylphenidate
US9694050B2 (en) 2012-10-21 2017-07-04 University Of Rochester THY1 (CD90) as a novel therapy to control adipose tissue accumulation
ES2621915T3 (es) 2012-10-25 2017-07-05 Noven Pharmaceuticals, Inc. Composiciones y métodos para la administración transdérmica de anfetamina
US20150104495A1 (en) * 2012-10-25 2015-04-16 Noven Pharmaceuticals, Inc. Compositions and methods for transdermal delivery of amphetamine
JP6050896B2 (ja) 2012-11-02 2016-12-21 テイコク ファーマ ユーエスエー インコーポレーテッド プロピニルアミノインダン経皮組成物
CN103845220B (zh) * 2012-12-04 2017-09-01 日绊株式会社 贴附剂
EP3712142B1 (en) 2013-01-11 2022-07-06 Corsair Pharma, Inc. Prodrugs of treprostinil
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
WO2014159582A1 (en) * 2013-03-14 2014-10-02 Noven Pharmaceuticals, Inc Amphetamine transdermal compositions with acrylic block copolymer
US20160220507A1 (en) * 2013-07-10 2016-08-04 Jie Zhang Kit for sustained transdermal drug delivery using liquid or semisolid formulations and method of using the same
US20160256407A1 (en) * 2013-10-11 2016-09-08 Xep, Inc. Energy patch
EP3086783B1 (en) * 2013-12-23 2018-08-29 Noven Pharmaceuticals, INC. Compositions and methods for transdermal delivery of amphetamine
US10307380B1 (en) 2014-03-04 2019-06-04 Prosolus, Inc. Composition and method for transdermal lidocaine delivery
US20160324241A2 (en) * 2014-08-08 2016-11-10 Yo Han Lee An adhesive device for attaching a false eyelash and a false eyelash kit
CA2974324A1 (en) 2015-01-28 2016-08-04 Zita S. Netzel Drug delivery methods and systems
WO2016145373A1 (en) 2015-03-12 2016-09-15 Chrono Therapeutics Inc. Craving input and support system
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9643911B2 (en) 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
SG11201805570WA (en) 2015-12-30 2018-07-30 Corium Int Inc Systems and methods for long term transdermal administration
US10493049B2 (en) 2016-02-10 2019-12-03 Niracle LLC Applicator-based transdermal drug delivery system for administration of drugs in combination with topical formulations
US10010511B2 (en) 2016-05-25 2018-07-03 Prosolus, Inc. Transdermal drug delivery system
JP7174632B2 (ja) 2016-06-23 2022-11-17 コリウム， インコーポレイテッド 親水性ドメインおよび疎水性ドメインならびに処置剤との接着剤マトリックス
US11198800B2 (en) * 2016-07-22 2021-12-14 Lts Lohmann Therapie-Systeme Ag Control of adhesive domains
EP3490559A1 (en) 2016-07-27 2019-06-05 Corium International, Inc. Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
CN116966166A (zh) 2016-07-27 2023-10-31 考里安有限责任公司 碳酸氢钠原位转化驱动胺药物的透皮递送
AU2017301929B2 (en) 2016-07-27 2023-03-02 Corium Pharma Solutions, Inc. Memantine transdermal delivery systems
EP3483229B1 (en) * 2016-08-04 2023-10-04 Toppan Printing Co., Ltd. Support film for tape material, tape material, and method for producing support film for tape material
US10736905B1 (en) 2016-09-09 2020-08-11 Shahin Fatholahi Nefopam dosage forms and methods of treatment
WO2018081761A1 (en) * 2016-10-31 2018-05-03 The Corporation Of Mercer University Transdermal delivery of phenethylamine monoamine releasers
US11337932B2 (en) 2016-12-20 2022-05-24 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
CN115813887A (zh) 2016-12-20 2023-03-21 罗曼治疗系统股份公司 包含阿塞那平的透皮治疗系统
EP3565617A1 (en) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
WO2018144694A1 (en) 2017-02-01 2018-08-09 Plakous Therapeutics, Inc. Placental tissue compositions
CA3067938A1 (en) 2017-06-26 2019-01-03 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer
US10736874B1 (en) 2017-09-08 2020-08-11 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US11446311B2 (en) 2017-09-08 2022-09-20 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
JP7225719B2 (ja) * 2017-11-15 2023-02-21 三菱ケミカル株式会社 有機／無機複合体粒子
AU2018392686A1 (en) 2017-12-20 2020-07-09 Corium Pharma Solutions, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
US20190231925A1 (en) * 2018-01-31 2019-08-01 Changchun Ja Biotech. Co., Ltd. Heparin sodium supported hydrogel sustained-release paster
CA3097189A1 (en) * 2018-04-25 2019-10-31 Shinkei Therapeutics Llc Tetrabenazine transdermal delivery device
WO2019232077A1 (en) 2018-05-29 2019-12-05 Chrono Therapeutics Inc. Drug delivery methods and systems
KR20210022656A (ko) 2018-06-20 2021-03-03 에르테에스 로만 테라피-시스테메 아게 아세나핀을 함유하는 경피 치료 시스템
US20200009074A1 (en) 2018-07-03 2020-01-09 Cosmed Pharmaceutical Co., Ltd. Supplement patch
WO2020036575A1 (en) * 2018-08-13 2020-02-20 Xinova, LLC Individually tailored delivery of agents to optimize efficacy
KR20220104705A (ko) * 2019-10-22 2022-07-26 신케이 테라퓨틱스 엘엘씨 테트라베나진 경피 전달 장치
CN111000834B (zh) * 2020-01-07 2023-03-17 中国人民解放军军事科学院军事医学研究院 一种阿姆西汀药物组合物、阿姆西汀贴剂及其制备方法和应用
US20230123388A1 (en) * 2020-04-14 2023-04-20 Glanis Pharmaceuticals, Inc. Transdermal and/or topical delivery system comprising hydroxychloroquine and/or chloroquine
IT202000011686A1 (it) * 2020-05-20 2021-11-20 Fidia Farm Spa Cerotto medicato a lento rilascio
CN111826764B (zh) * 2020-07-28 2021-10-15 吴忠德悦纺织科技有限公司 一种改性多组份复合纱线的制备方法
EP4275055A2 (en) 2021-01-07 2023-11-15 Noven Pharmaceuticals, Inc. Amphetamine carbamate compounds and methods
US11559501B2 (en) 2021-01-07 2023-01-24 Noven Pharmaceuticals, Inc. Transdermal amphetamine compositions with low levels of carbamate
CN117396195A (zh) * 2021-03-30 2024-01-12 晖致公司 具有低剂量雌激素的透皮系统及其制造和使用方法
CN117545474A (zh) 2021-11-08 2024-02-09 李维庸 一种用于向患者递送药物的透皮给药系统
EP4338740A1 (en) 2022-09-13 2024-03-20 Johannes Gutenberg-Universität Mainz A transdermal patch for promoting or accelerating myelination and/or remyelination

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5843368B2 (ja) * 1980-10-30 1983-09-27 日東電工株式会社 消炎鎮痛貼付剤
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
US4584355A (en) * 1984-10-29 1986-04-22 Dow Corning Corporation Silicone pressure-sensitive adhesive process and product with improved lap-shear stability-I
US4655767A (en) * 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US4591622A (en) * 1984-10-29 1986-05-27 Dow Corning Corporation Silicone pressure-sensitive adhesive process and product thereof
US4585836A (en) * 1984-10-29 1986-04-29 Dow Corning Corporation Silicone pressure-sensitive adhesive process and product with improved lap-shear stability-II
US4994278A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Breathable backing
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
US5246705A (en) * 1992-04-08 1993-09-21 Cygnus Therapeutic System Occlusive, elastomeric backing materials in transdermal drug delivery systems, and associated methods of manufacture and use
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
US5474787A (en) * 1994-10-21 1995-12-12 The Wm. Wrigley Jr. Company Chewing gum containing a lecithin/glycerol triacetate blend
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
ES2252865T3 (es) * 1997-09-26 2006-05-16 Noven Pharmaceuticals, Inc. Composiciones bioadhesivas y metodos para la administracion topica de agentes activos.
US6660295B2 (en) * 1997-09-30 2003-12-09 Alza Corporation Transdermal drug delivery device package with improved drug stability
US20030170195A1 (en) 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
AU1436402A (en) * 2000-11-06 2002-05-15 Samyang Corp Transdermal drug delivery system with improved water absorbability and adhesion properties
US6448303B1 (en) * 2000-12-29 2002-09-10 National Starch And Chemical Investment Holding Corporation Hot melt adhesives for dermal application
WO2005046600A2 (en) * 2003-11-07 2005-05-26 Nexmed Holdings, Inc. Transdermal tulobuterol delivery
ES2526700T3 (es) * 2004-08-05 2015-01-14 Corium International, Inc. Composición de adhesivo
KR20070072867A (ko) 2004-09-01 2007-07-06 넥스메드 홀딩스 인코포레이티드 경피성 항구토 전달 시스템, 이의 방법 및 조성물
CA2583340C (en) 2004-10-08 2015-09-08 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing

Also Published As

Publication number Publication date
US20160128949A1 (en) 2016-05-12
WO2006044206A3 (en) 2006-08-10
US10231938B2 (en) 2019-03-19
EP1807033A2 (en) 2007-07-18
ES2596809T3 (es) 2017-01-12
WO2006044206A2 (en) 2006-04-27
US8815281B2 (en) 2014-08-26
US20120269881A9 (en) 2012-10-25
US20110097384A1 (en) 2011-04-28
TW200628175A (en) 2006-08-16
CA2583340C (en) 2015-09-08
US20120165762A1 (en) 2012-06-28
US9155712B2 (en) 2015-10-13
CA2583340A1 (en) 2006-04-27
EP1807033B1 (en) 2016-07-20
US20150157578A1 (en) 2015-06-11
AR053309A1 (es) 2007-05-02
US8591941B2 (en) 2013-11-26
EP1807033A4 (en) 2009-12-30
MX2007004315A (es) 2008-03-11
US20060078604A1 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
PE20060491A1 (es) Dispositivo transdermico de transmision de farmaco que incluye un refuerzo oclusivo
CL2014001559A1 (es) Sistema terapeutico transdermico que comprende una estructura de capa autoadhesiva que contiene buprenorfina la cual comprende a) una capa de respaldo impermeable a buprenorfina y b) una capa adhesiva sensible a la presion que contiene buprenorfina, la cual contacta la piel y que comprende al menos un adhesivo, buprenorfina y un acido carboxilico; su metodo de fabricacion, util para tratar el dolor.
MX2009005327A (es) Material/dispositivo hemostatico nanoestratificado, funcional.
EP2848248A3 (en) Amorphous drug transdermal systems, manufacturing methods, and stabilization
WO2007092894A3 (en) Drug delivery system and method of manufacturing thereof
ATE375790T1 (de) Fentanyl enthaltende pflasterzubereitung
ATE533451T1 (de) Klebender wafer
ATE402663T1 (de) Flächiges implantat
ATE488228T1 (de) Klebstoffzubereitung
MX337361B (es) Sistema de entrega de medicamento transdermico que comprende una capa de liberacion recubierta.
WO2005007020A3 (en) Wound dressing, ingredient delivery device and iv hold-down, and method relating to same
Miyazaki et al. An ultrathin poly (l‐lactic acid) nanosheet as a burn wound dressing for protection against bacterial infection
BRPI0510723A (pt) artigo antimicrobiano, método para fornecer um artigo antimicrobiano, e, curativo de ferimento
ATE424800T1 (de) Vernetzter nagellackfilm
PL2529732T3 (pl) Transdermalny system terapeutyczny zawierający warstwę przyczepną, sposób silikonowania warstwy tylnej systemu i zastosowanie tej warstwy tylnej
BR112012012099A2 (pt) sistema de revestimento de superfície e seu método de uso
AR054012A1 (es) Sistema terapeutico transdermico para la adminstracion de analgesicos
MY183873A (en) Transdermal therapeutic system for application of an agent
AR043248A1 (es) Sistema terapeutico transdermico estable a los rayos uv
AR070031A1 (es) Sistemas de administracion transdermicos de droga ketotifen y metodos para el tratamiento de enfermedades oftalmicas
WO2009147641A3 (en) A device and a system for delivery of biological material
ATE499930T1 (de) Vorrichtung zur transdermalen arzneimittelverabreichung
CY1120773T1 (el) Ενα συστημα παροχης φαρμακου
MA31145B1 (fr) Composition antivirale et procede d'utilisation
WO2012091408A3 (en) Matrix type antimicrobial vehicle and manufacturing method thereof

Legal Events

Date Code Title Description
FC Refusal